Generic human leukocyte antigen class II (DRB1 and DQB1) alleles in patients with paracoccidioidomycosis

References

• Wanke B, Londero AT. Epidemiology and paracoccidioidomycosis infection. Paracoccidioidomycosis, M. Franco, CS Lacaz, A Restrepo-Moreno, G Del Negro. CRC Press, Boca Raton 1994; 109–130
   Google Scholar
• Franco M, Montenegro MR, Mendes RP, et al. Paracoccidiodomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop 1987; 20: 129–132
   PubMedGoogle Scholar
• Calich VLG, Singer-Vermes LM, Siqueira AM, Burger E. Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br J Exp Pathol 1985; 66: 585–594
   PubMedGoogle Scholar
• Calich VLG, Burger E, Kashino SS, Fazioli RA, Singer-Vermes LM. Resistance to Paracoccidioides brasiliensis in mice is controlled by a single dominant autosomal gene. Infect Immun 1987; 55: 1919–1923
   PubMed Web of Science ®Google Scholar
• Lacerda GB, Arce-Gomez B, Telles Filho FQ. Increased frequency of HLA-B40 in patients with paracoccidioidomycosis. J Med Vet Mycol 1988; 26: 253–256
   PubMedGoogle Scholar
• Restrepo FM, Restrepo M, Restrepo A. Blood groups and HLA antigens in paracoccidioidomycosis. Sabouraudia 1983; 21: 35–39
   PubMedGoogle Scholar
• Goldani LZ, Monteiro CM, Donadi EA, Martinez R, Voltarelli JC. HLA antigens in Brazilian patients with paracoccidioidomycosis. Mycopathologia 1991; 114: 89–91
   PubMed Web of Science ®Google Scholar
• Balarin MAS, Freire-Maia DV. Associação entre glioxalase I e paracoccidioidomicose-infecção. Rev Soc Bras Med Trop 1993; 26: 141–143
   PubMedGoogle Scholar
• Dias MF, Pereira AC, Pereira A, Alves MS. The role of HLA antigens in the development of paracoccidioidomycosis. J Eur Acad Dermatol Venereol 2000; 14: 166–171
   PubMed Web of Science ®Google Scholar
• Rebellato CLK. Estudo da associação entre os antígenos HLA-A, B, C, DR e DQ e a paracoccidioidomicose infecção e a forma crônica da paracoccidioidomicose doença. PhD thesis, Universidade Federal do Paraná, 1996.
   Google Scholar
• Gustincich S, Manfioletti G, Del Sal GS, Schneider G, Carninci PA. Fast method for high quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11: 298–300
   PubMed Web of Science ®Google Scholar
• Zar JH. Biostatistical analysis. Prentice Hall, Inc, Englewood Cliff, NJ 1984; 401–403
   Google Scholar
• Klein J, Sato A. The HLA system. N Engl J Med 2000; 7: 782–786
   Google Scholar
• Thursz M, Yallop R, Goldin R, et al. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. Lancet 1999; 354: 2119–2124
   PubMed Web of Science ®Google Scholar
• Alric L, Fort M, Izopet J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997; 113: 1675–1681
   PubMedGoogle Scholar
• Minton EJ, Smillie D, Neal KR, et al. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis 1998; 178: 39–44
   PubMed Web of Science ®Google Scholar
• Cramp ME, Carucci P, Underhill J, et al. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 1998; 29: 207–213
   PubMed Web of Science ®Google Scholar
• Zavaglia C, Martinetti M, Silini E, et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 1998; 28: 1–7
   PubMed Web of Science ®Google Scholar
• Renou C, Halfon P, Pol S, et al. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut 2002; 51: 585–590
   PubMed Web of Science ®Google Scholar
• Taylor ML, Pérez-Mejía A, Yamomoto-Furusho JK, Granados J. Immunologic, genetic and social human risk factors associated to histoplasmosis: Studies in the State of Guerrero, México. Mycopathologia 1997; 138: 137–141
   PubMedGoogle Scholar
• Dabil H, Kaplan HJ, Duffy BF, et al. A. Association of the HLA-DR15/HLA-DQ6 haplotype with development of choroidal neovascular lesions in presumed ocular histoplasmosis syndrome. Hum Immunol 2003; 64: 960–964
   PubMedGoogle Scholar
• Tsuneto LT, Arce-Gomez B, Petzl-Erler ML, Queiroz-Telles F. HLA-A29 and genetic susceptibility to chromoblastomycosis. J Med Vet Mycol 1989; 27: 181–185
   PubMedGoogle Scholar
• Sadahiro A, Moraes JRF, Moraes MEH, et al. HLA in Brazilian Ashkenazic Jews with chronic dermatophytosis caused by Trichophyton rubrum. Braz J Microbiol 2004; 35: 69–73
   Google Scholar
• Louie L, Ng S, Hajjeh R, et al. Influence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis 1999; 5: 672–680
   PubMed Web of Science ®Google Scholar
• Beck HP, Felger I, Barker M, et al. Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population. Am J Trop Med Hyg 1995; 53: 284–288
   PubMedGoogle Scholar
• Dubaniewicz A, Moszkowska G, Szczerkowska Z. Frequency of DRB1-DQB1 two-locus haplotypes in tuberculosis: preliminary report. Tuberculosis 2005; 85: 259–267
   PubMedGoogle Scholar
• Mangia A, Gentile R, Cascavilla I, et al. HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol 1999; 30: 984–989
   PubMed Web of Science ®Google Scholar
• Hue S, Cacoub P, Renou C, et al. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Infect Dis 2002; 186: 106–109
   PubMed Web of Science ®Google Scholar
• Tillmann HL, Chen DF, Trautwein C, et al. Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 2001; 48: 714–718
   PubMed Web of Science ®Google Scholar
• Yenigun A., Durupinar B. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection. J Virol 2002; 76: 1787–1789
   PubMed Web of Science ®Google Scholar
• Chaudhuri S, Cariappa A, Tang M, et al. Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc Natl Acad Sci USA 2000; 97: 11451–11454
   PubMed Web of Science ®Google Scholar
• Kwon OJ, Brautbar C, Weintrob N, et al. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients. Hum Immunol 2001; 62: 85–91
   PubMed Web of Science ®Google Scholar
• Volpini WM, Testa GV, Marques SB, et al. Family-based association of HLA class II alleles and haplotypes with type I diabetes in Brazilians reveals some characteristics of a highly diversified population. Hum Immunol 2001; 62: 1226–1233
   PubMedGoogle Scholar
• Pirim I., Atasoy M., Ikbal M., Erdem T, Aliagaoglu C. HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. Tissue Antigens 2004; 64: 293–297
   PubMedGoogle Scholar
• Lombardi ML, Mercuro O, Pirozzi G, et al. Molecular analysis of HLA DRB1 and DQB1 polymorphism in Italian melanoma patients. J Immunother 1998; 21: 435–439
   PubMedGoogle Scholar
• Loiseau P, Lepage V, Djelal F, et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum Immunol 2001; 62: 725–731
   PubMedGoogle Scholar
• Hodak E, Lapidoth M, Kohn K, et al. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients. Br J Dermatol 2001; 145: 974–980
   PubMedGoogle Scholar
• Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 2003; 29: 225–231
   PubMed Web of Science ®Google Scholar